Copyright 2012, National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov/funding/funding_announcements/RSS_Funding.htm en Funding Announcements Saturday Sunday http://blogs.law.harvard.edu/tech/rss http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-13-208 .htm http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-13-208 .htm This Funding Opportunity Announcement (FOA) encourages grant applications for Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01s). The mission of the CounterACT U01 program is to develop new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, and pesticides. Applicants are encouraged to contact the Program Officials listed in this FOA to determine if their proposed threat agent(s) or countermeasure(s) is of high program priority for one of the participating Institutes. The scope of the research to be supported includes target and candidate identification and characterization, through candidate optimization and demonstration of in vivo efficacy, through Investigational New Drug (IND) submission when appropriate. Each project must include milestones that create discrete go or no-go decision points in a progressive translational study plan. Thu, 25 Apr 2013 00:00:00 EDT http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-13-016.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-13-016.htm The purpose of this funding opportunity announcement (FOA) is to invite applications to participate as a National Data Management Center for the NINDS Stroke Trials Network. Separate FOAs have been issued to solicit applications for the Regional Coordinating Stroke Centers (RFA-NS-13-011) and the National Clinical Coordinating Center (RFA-NS-13-012). The primary goal of this network is to maximize efficiencies to develop, promote and conduct high-quality, multi-site exploratory phase 1/2 and confirmatory phase 3 clinical trials focused on key interventions, as well as biomarker-validation studies that are immediately preparatory to trials, in stroke prevention, treatment, and recovery with the objective to have a balanced portfolio between all three approaches. The network will include multiple regional coordinating stroke centers around the U.S. representing a larger number of community stroke centers all coordinated through separate National Clinical Coordinating and Data Management Centers. Thu, 18 Apr 2013 00:00:00 EDT http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-13-013.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-13-013.htm This initiative will support a multicenter, systematic and comprehensive investigation of the neuropathology of Chronic Traumatic Encephalopathy and the delayed effects of traumatic brain injury using postmortem biospecimens, and histological and neuroimaging tools as a foundation for future studies to develop in vivo diagnostics. Mon, 18 Mar 2013 00:00:00 EDT http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-13-014.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-13-014.htm This initiative will support pilot projects on sports-related traumatic brain injury and spinal cord injury. Mon, 18 Mar 2013 00:00:00 EDT http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-13-015.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-13-015.htm This initiative will support pilot projects on sports-related traumatic brain injury and spinal cord injury. Mon, 18 Mar 2013 00:00:00 EDT http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-13-011.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-13-011.htm The purpose of this funding opportunity announcement (FOA) is to invite applications to participate as a Regional Coordinating Stroke Center in the NINDS Stroke Trials Network. The primary goal of this network is to maximize efficiencies to develop, promote and conduct high-quality, multi-site clinical trials focused on key interventions in stroke prevention, treatment, and recovery with the objective to have a balanced portfolio between all three approaches. Exploratory phase 1, 2 and confirmatory phase 3 clinical trials as well as biomarker-validation studies that are immediately preparatory to trials will be coordinated through separate National Clinical Coordinating and Data Management Centers. Mon, 11 Mar 2013 00:00:00 EDT